Novo Nordisk | NVO - Pre Utilidad Fiscal

Precio De Mercado
39.35
Cambio Diario
1.38 3.63%
Mensual
2.08%
Anual
-38.96%
Q2 Expectativa
35.64




Pre Utilidad Fiscal Cambio Fecha
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bausch Health Companies USD 218M 78M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Drreddys Laboratories INR 15.43B 1.96B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Merck USD 6.74B 22M 2025-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 4.64B 445M 2025-12
Novo Nordisk DKK 33.8B 3.23B 2025-06
Novo Nordisk DKK 25.52B 8.29B 2025-09
Pacira USD 9.52M 11.45M 2025-09
Perrigo USD 22.4M 19.2M 2025-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 69.13M 7.35M 2025-09
Sanofi EUR -1.16B 5.5B 2025-12
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Zoetis USD 887M 15M 2025-09